# EDGAR Filing Document

**Accession Number:** 0001535610
**File Stem:** 0001013594-25-000896
**Filing Date:** 2025-8
**Character Count:** 12797
**Document Hash:** bfd625a849e1de9ae222f3f60db7582e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001013594-25-000896.hdr.sgml**: 20250804

**ACCESSION NUMBER**: 0001013594-25-000896

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250804

**EFFECTIVENESS DATE**: 20250804

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SABBY MANAGEMENT, LLC
- **CENTRAL INDEX KEY:** 0001535610

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-15245
- **FILM NUMBER:** 251180025

**BUSINESS ADDRESS:**
- **STREET 1:** 1011 LINKS DR
- **CITY:** MIAMI BEACH
- **STATE:** FL
- **ZIP:** 33109
- **BUSINESS PHONE:** 646-307-4500

**MAIL ADDRESS:**
- **STREET 1:** 1011 LINKS DR
- **CITY:** MIAMI BEACH
- **STATE:** FL
- **ZIP:** 33109

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001535610

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** SABBY MANAGEMENT, LLC

**Address:** 1011 LINKS DR, MIAMI BEACH, FL 33109

**Telephone number:** 646-307-4500

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-15245

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER               | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                                                                                                                                                                   | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED    |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Acurx Pharmaceuticals, Inc.  | 00510M104 | 07/17/2025     | To approve an amendment to the Company's 2021 Equity Incentive Plan to increase the number of shares of common stock available for sale from 177,448 to 2,677,448                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| Can-Fite BioPharma Ltd.      | 13471N102 | 06/23/2025     | To approve the grant of options to Dr. Pnina Fishman, Chairman of the Board of Directors                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| Can-Fite BioPharma Ltd.      | 13471N102 | 06/23/2025     | To approve the grant of options to Mr. Motti Farbstein, Chief Executive Officer                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| Hepion Pharmaceuticals, Inc. | 426897401 | 03/10/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| Imunon, Inc.                 | 15117N602 | 07/11/2025     | To approve, by a non-binding advisory vote, the 2024 executive compensation for the Company's executive officers                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| Imunon, Inc.                 | 15117N602 | 07/11/2025     | To approve an Amendment to the IMUNON, INC. 2018 Stock Incentive Plan to increase the aggregate number of shares of common stock that may be delivered pursuant to all awards granted under the 2018 Plan                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| Pineapple Energy Inc.        | 72303P305 | 07/01/2024     | To conduct a non-binding advisory vote approving executive compensation                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| Pineapple Energy Inc.        | 72303P305 | 07/01/2024     | To conduct a non-binding advisory vote on the frequency of future advisory votes on executive compensation                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| Pineapple Energy Inc.        | 72303P305 | 07/01/2024     | To approve amendments to the Pineapple Energy Inc. 2022 Equity Incentive Plan to increase the number of shares of common stock authorized for issuance under the 2022 Equity Incentive Plan, and the number of shares that can be issued as incentive stock options under the 2022 Equity Incentive Plan                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| PMGC Holdings Inc.           | 28622K203 | 03/26/2025     | To approve the issuance of 3,036,437 shares of non-trading, non-convertible Series B Preferred Stock to GB Capital Ltd, a British Columbia, Canada corporation (“GB Capital”) wholly owned by Chief Executive Officer, Chief Financial Officer, and Director, Graydon Bensler, as a signing bonus pursuant to that certain Second Amended and Restated Consulting Agreement for Non-Employee Chief Executive Officer between the Company and GB Capital as amended | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| PMGC Holdings Inc.           | 28622K203 | 03/26/2025     | To approve the issuance of 3,336,437 shares of non-trading, non-convertible Series B Preferred Stock to Northstrive Companies Inc. (“Northstrive”), a California corporation wholly owned by Chairman, Braeden Lichti, as a signing bonus pursuant to that certain Second Amended and Restated Consulting Agreement for Non-Executive Chairman between the Company and Northstrive, as amended                                                                     | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| Revelation Biosciences, Inc. | 76135L705 | 06/23/2025     | To approve amendment to the company's 2021 Equity Incentive Plan                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| Revelation Biosciences, Inc. | 76135L705 | 06/23/2025     | To approve advisory vote on executive compensation                                                                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |
| Revelation Biosciences, Inc. | 76135L705 | 06/23/2025     | To approve advisory vote on frequency of vote on executive compensation                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 | DID NOT VOTE |                                        0 | NONE                        |  |

## N-PX: Signature Block

**Reporting Person:** SABBY MANAGEMENT, LLC

**By (Signature):** Robert Grundstein

**By (Printed Signature):** Robert Grundstein

**By (Title):** Chief Operating Officer

**Date:** 08/04/2025